%0 Generic
%A Piulats Rodriguez, J. M.
%A Patel, S.
%A Espinosa, E.
%A Pelster, M. S.
%A de la Cruz Merino, L.
%A Khoja, L. T.
%A Joshua, A. M.
%A Tebe, C.
%A Berrocal, A.
%T Nivolumab and ipilimumab (N plus I) is active in patients (pts) with metastatic uveal melanoma (mUM) with extra-hepatic only involvement: Pooled analysis from 2 phase II trials
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/27551
%~